The biochemistry, enzymology and pharmacology of non-vitamin K anticoagulant drug reversal agents and antidotes

J Thromb Thrombolysis. 2016 Feb;41(2):273-8. doi: 10.1007/s11239-015-1286-3.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal, Humanized* / pharmacokinetics
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Anticoagulants* / adverse effects
  • Anticoagulants* / pharmacokinetics
  • Anticoagulants* / therapeutic use
  • Antidotes* / pharmacokinetics
  • Antidotes* / therapeutic use
  • Clinical Trials as Topic
  • Factor Xa* / pharmacokinetics
  • Factor Xa* / therapeutic use
  • Humans
  • Recombinant Proteins* / pharmacokinetics
  • Recombinant Proteins* / therapeutic use
  • Vitamin K

Substances

  • Antibodies, Monoclonal, Humanized
  • Anticoagulants
  • Antidotes
  • PRT064445
  • Recombinant Proteins
  • Vitamin K
  • idarucizumab
  • Factor Xa